This episode introduced Continuous Glucose Monitoring (CGM) in Internal Medicine Residency Continuity hospital. We started following the blood glucose accompanying CGM in 11-patients accompanying type 1 and Type 2 diabetes mellitus (DM 1 and DM 2) uncontrolled on 3-4 injections of Insulin per era. Continuous glucose monitoring is guide improved well-being behaviors and effects, such as reductions in glycated hemoglobin (HbA1c), hypoglycemia, carcass weight, and caloric consumption, and increases in physical activity, treatment vindication, and adherence to a private eating planThe CGM was begun by Internal Medicine and Transitional year Residents who made the CGM team and adaptation of the Insulin dose established the CGM data was done energetically by them under the project of Board-Certified Endocrinologist who was a appendage of the clinic.The goal search out show improvement of patient’s HbA1c calculated by glucose administration Indicator. The other goal search out decrease the time give by our patients in level 1 hypoglycemia betwixt 69-54 mg/dl and in level 2 hypoglycemia less than 54 mg/dl to less than 4% and 1 % individually per day. The additional target of our project was success of blood glucose between 70-180 mg/dl - be present at range (TIR) in 24-hour ending of 50-70% of the time and achievement of depressed glucose instability measured by cooperative of variation(CV) of less than 36% per epoch.
Author(s) Details:
Andre Manov,
Internal Medicine Residency Program, Sunrise
Health GME Consortium, Las Vegas, Nevada, USA.
Elizabeth
Benge,
Internal
Medicine Residency Program, Sunrise Health GME Consortium, Las Vegas, Nevada,
USA.
Samera Baig ,
Department of Chemical Engineering, Agni College of Technology,
Chennai-130, India.
Sukhjinder Chauhan,
Internal Medicine Residency Program, Sunrise Health GME Consortium, Las
Vegas, Nevada, USA.
Please
see the link here: https://stm.bookpi.org/RHDHR-V9/article/view/10978
No comments:
Post a Comment